Online inquiry

IVTScrip™ mRNA-Human ATAD2B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25137MR)

This product GTTS-WK25137MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATAD2B protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001242338.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 54454
UniProt ID Q9ULI0
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATAD2B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25137MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK5457MR IVTScrip™ mRNA-Human CD45RB, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA CD45RB
GTTS-WK27820MR IVTScrip™ mRNA-Human ASNS, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ASNS
GTTS-WK9550MR IVTScrip™ mRNA-Human ADH7, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADH7
GTTS-WK21012MR IVTScrip™ mRNA-Human AGPAT6, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AGPAT6
GTTS-WK16515MR IVTScrip™ mRNA-Human AGR3, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AGR3
GTTS-WK26829MR IVTScrip™ mRNA-Human ARIH1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARIH1
GTTS-WK14853MR IVTScrip™ mRNA-Human Aminopeptidase-N, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Aminopeptidase-N
GTTS-WK28135MR IVTScrip™ mRNA-Human ATAD1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ATAD1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW